Monetti, M <br/><br/>
Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.  [electronic resource] 

 -  Pharmacological research  May 2007 
 - 441-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-6618 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2007.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Aorta--drug effects<br/>Aortic Valve--drug effects<br/>Apolipoproteins E--deficiency<br/>Atherosclerosis--chemically induced<br/>Cardiovascular Agents--pharmacology<br/>Cholesterol--metabolism<br/>Cholesterol, Dietary<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorobenzenes--pharmacology<br/>Intercellular Adhesion Molecule-1--metabolism<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Knockout<br/>Pyrimidines--pharmacology<br/>Rosuvastatin Calcium<br/>Sulfonamides--pharmacology<br/>Thromboplastin--metabolism<br/>Time Factors<br/>Vascular Cell Adhesion Molecule-1--metabolism